Glioblastoma Market Is Driven by Rising Incidence Rates
The glioblastoma market encompasses a range of advanced therapeutic products designed to diagnose and treat glioblastoma multiforme (GBM), the most aggressive and common form of primary brain cancer. Key offerings include surgical instruments and devices for maximal tumor resection, radiation delivery systems such as stereotactic radiosurgery platforms, chemotherapeutic agents like...
0 Commentarii 0 Distribuiri 196 Views 0 previzualizare